Learning nominates a cathepsin role in lung cancer cells
Source check: Source checked. Not independent scientific confirmation.
Finding: CoxBoost and elastic-net selection included CTSH in a seven-gene lung-cancer signature. Subsequent experiments in HCC827 cells found that reducing CTSH increased migration and invasion and reduced apoptosis. This supports a model-specific functional role after learned candidate selection; it does not establish a protective effect in patients, a treatment or an in-vivo mechanism.
Technology: CoxBoost; elastic-net survival regression
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- CoxBoost and elastic net nominate a seven-gene signature containing CTSH, which the authors select for subsequent functional cell experiments.
- Test and result
- Learned candidate selection followed by CTSH perturbation and measured cell migration, invasion and apoptosis in one lung-cancer cell line.
- Limitation / still unknown
- In-vivo confirmation, broader cell-model generalization and therapeutic benefit remain unestablished; survival models were selected using validation-cohort performance.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10590321/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.